Atopic Dermatitis & Psoriasis

Inflammatory skin diseases are common and associated with highly visible signs (redness, dryness, scaling), psychosocial burden, and systemic comorbidities. Recent scientific advances have improved our understanding of inflammatory skin diseases and have led to many new treatment options, some already FDA-approved and other emerging. However, not all treatments are approved for use in children and questions remain about the long-term effects of these treatments, including side effects and impact on disease course and risk of associated disorders.

The goals of the Atopic Dermatitis and Psoriasis Focused Study Group are to define and address unmet research needs in inflammatory skin diseases, to discover new therapies, and to advance our understanding of biomarkers, genetic influences, and disease comorbidities.

The AD & Psoriasis Breakout Session at the 2025 PeDRA Annual Conference.

Co-Chairs

The AD & Psoriasis Focused Study Group is Chaired by Joy Wan, MD of Johns Hopkins University, and Vice-Chaired by Tina Ho, MD, PhD of Boston Children’s Hospital.

Joy Wan, MD
Chair

Johns Hopkins University


Tina Ho, MD, PhD
Vice Chair

Boston Children’s Hospital


Questions or looking to get involved?

Email us to get connected to the Atopic Dermatitis & Psoriasis group or to learn more.

WordPress Ads